Agenus UK Ltd
Life Sciences
Agenus uses the power of the immune system to develop innovative product candidates against cancer.
- Sector Life Sciences
Agenus uses the power of the immune system to develop innovative product candidates against cancer.
Its technologies and candidates have the potential to treat cancer as well as other immune-mediated diseases. The company has assembled a broad portfolio of antibodies including checkpoint inhibitors and other checkpoint modulators, neo-antigen vaccines and adjuvants. Agenus’ strategy combines its intellectual and technical assets with its broad pipeline with the aim of bringing curative treatments to cancer patients.
Contact us
Thank you for your enquiry!
We'll be in touch soon.